Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT - Top-Institutions - MDSpire

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

  • By

  • Nico Gagelmann

  • Maximilian Merz

  • Laurien G. A. Baaij

  • Linda Koster

  • Jorinde D. Hoogenboom

  • Joanna Drozd-Sokolowska

  • Kavita Raj

  • Jürgen Kuball

  • Patrick J. Hayden

  • Florent Malard

  • Laurent Garderet

  • Annalisa Ruggeri

  • Donal McLornan

  • March 31, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy
    • Multiple Myeloma

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy
    • Multiple Myeloma

  • #3

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy
    • Multiple Myeloma

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy
    • Multiple Myeloma

  • #5

    University College London Hospitals (UCLH)
    University College London Hospitals (UCLH)

    London, England

    Key Differentiators

    • Hematology
    • Oncology
    • Cellular Therapy
    • Multiple Myeloma

Original Source(s)

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

  • by Nico Gagelmann, Maximilian Merz, Laurien G. A. Baaij, Linda Koster, Jorinde D. Hoogenboom, Joanna Drozd-Sokolowska, Kavita Raj, Jürgen Kuball, Patrick J. Hayden, Florent Malard, Laurent Garderet, Annalisa Ruggeri, Donal McLornan

  • March 31, 2026

Related Content

Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review

A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma